Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event

Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01395550

Enrollment

Registered

2011-07-15

Start date

2010-01-31

Completion date

2010-07-31

Last updated

2011-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Events

Brief summary

AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients who has experienced cardiovascular events

Exclusion criteria

* Patients with no cardiovascular events.

Outcome results